Drugmaker

Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021.Dado Ruvic | ReutersBiotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion. Shares of ImmunoGen jumped more than 80% Thursday, putting it on track for its highest close since November 2000. Meanwhile, AbbVie's stock rose more than 2%. ImmunoGen develops cancer drugs called antibody-drug conjugates, or ADCs, which are designed to directly kill cancer cells and spare…

The activist is pushing for a shake-up of the contract drug manufacturer’s board. The activist is pushing for a shake-up of the contract drug manufacturer’s board. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to…

Fast News Merck's financial results were better than expected in the fourth quarter of 2022 thanks in part to strong sales of its cancer drugs, and despite a decline in its anti-Covid treatment molnupiravir. The transaction diversifies Merck's portfolio and will help drive its "growth…

HONG KONG—Chinese authorities have arrested an employee of Japanese drugmaker Astellas Pharma Inc., ALPMY 0.38% the second detention of foreign company staff to have surfaced in recent days and when Beijing is seeking to reassure the business community of its commitment to an open policy. China informed the Japanese Embassy that one of its nationals, a man in his 50s, had been detained in Beijing, Japan’s chief spokesman…

Image: Daniel Beckemeier (Shutterstock)An Insulin drugmaker announced it is making its drug more affordable for some diabetics and is capping the out-of-pocket cost at $35 per month. Eli Lilly is making Insulin immediately available to seniors on Medicare. It’s welcome news to the many Americans who rely on insulin, as the cost of care has soared in recent years.The company is automatically applying the price cap for Insulin to seniors who have private insurance and those without can sign up for Eli Lilly’s copay…

Endo International PLC, the pharmaceutical manufacturer facing thousands of lawsuits alleging it fueled the opioid addiction crisis, said Tuesday that it is likely to file for bankruptcy imminently. The company said that it is in negotiations with a group of senior lenders that it expects will result in an agreement for a chapter 11 filing. Endo also said that it is in discussions with opioid litigants as well as other creditors but didn’t say that it has reached a proposed deal with them.…

An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021.Mike Segar | ReutersDrugmaker Eli Lilly, one of the biggest employers in Indiana, said that the state's newly passed law restricting abortions will cause the company to grow away from its home turf.Lilly said in a statement on Saturday that it recognizes abortion as a "divisive and deeply personal issue with no clear consensus among the citizens of Indiana.""Despite this lack of agreement,…

The birth-control pill is among one of the most common methods of contraception used by women ages 15 to 49, according to the CDC. Photo: Rich Pedroncelli/Associated Press…

Fidson Healthcare is to pay shareholders over N1 billion in dividend and also issue them one new share for every 10 they own in the company, both representing the planned compensation for holders of its common stock for the financial year 2021. The cash reward proposal enables shareholders to get a dividend of N0.50 per share, with qualification date for it as well as the scrip issue set for July 8, the pharmaceutical firm said on Friday in a note to the Nigerian Exchange Limited. Fidson will have doled out…